Building the AMR Independent Panel: Lessons and Insights
A collaborative initiative to explore models, lessons, and frameworks to support the Independent Panel on Evidence for Action Against Antimicrobial Resistance
In September 2024, countries tasked the UN with establishing an Independent Panel on Evidence for Action Against Antimicrobial Resistance. To aid the formation of this panel, CGD has worked with a range of researchers to create a collection of papers designed to learn from existing independent panels and to incorporate the goals of AMR stakeholders.

Explore our Work on the Independent Panel on AMR

Analysis and Commentary

  • Evaluating Existing Processes for Uptake of Scientific Evidence on AMR
    Antimicrobial resistance (AMR) represents one of the most pressing global health challenges, yet translating scientific evidence i...
  • Evaluating Existing Independent and Intergovernmental Panels in Animal Health
    For the new Independent Panel on Evidence for Action against AMR to be effective, it will need to combine strong mandates, indepen...
  • Eight Lessons for Building an Independent Panel on AMR
    Antimicrobial resistance (AMR) is one of the greatest health challenges of our time, responsible for 1.14 million deaths a year. F...
  • Understanding Lessons from the IPCC to Inform the AMR Panel
    The Intergovernmental Panel on Climate Change has become a reference point for the design of international scientific advisory bod...
  • What the Independent Panel for Evidence for Action Against AMR Can Learn from Other Health Panels
    The paper reviews lessons from 17 global health panels to inform the design of the forthcoming Independent Panel for Evidence for ...
  • Antimicrobial Resistance is Dangerous in More Ways Than One
    Financial Times op-ed by Anthony McDonnell.
  • Diagnosing and Solving the Economic Drivers of Antibiotic Resistance
    The process of discovering, producing, buying, and consuming antibiotics is riddled with market and government failures. To solve ...
  • Improving the Antimicrobial Market for Human Health
    In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should si...
  • Overcoming Barriers to Improve Antimicrobial Access
    India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procureme...
  • Leveraging Brazilian Leadership in the Fight Against Antimicrobial Resistance
    Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and...
  • G7 Investments in New Antibiotics Would Pay Off Big—For Everyone
    The world desperately needs new antibiotics—and finally, the G7 is ready match commitments with action. We already found that the ...
  • A Proposed US Program to Develop New Antibiotics Would Pay Off 28:1
    Congress has excellent legislation on the docket that would protect American citizens, yield huge returns, and create a safer, hea...
  • The UK's Role in Fighting Antimicrobial Resistance
    To reduce the threat of antimicrobial resistance, the UK must increase investment in water, sanitation and hygiene (wash) overseas...

Contact

Anthony McDonnell, Policy Fellow

Contact

Anthony McDonnell, Policy Fellow

Acknowledgments

With thanks to:

Ayodele A. Akinyele, Jonathan Beynon, Geneviève Boily-Larouche, Francesca Chiara, Suzanne Edwards, Maple Goh, Javier Guzman, Hannah Hughes, Misbah Khan, Eli Kahn-Woods, Iruka Okeke, Emmanuel Olamijuwon, Kevin Outterson, Mathieu JP Poirier, Arne Ruckert, Sahran Shafaque, Asti Shafira, South Centre, Viviana Munoz Tellez, Olafur Valsson